Docket Number:10A-990524
Inventor:Wu, H. C., Liu, I. J., Chiu C. Y.
IP Status:US provisional
Abstract:
The present invention relates to a dengue autoantibody and protein identity of autoantigen, and application thereof. This human autoantigen and B-cell epitope of autoantibody can be used clinically to prevent damage by dengue autoantibodies.
Fields of Application:
- Development of diagnostic reagents for dengue hemorrhagic fever.
- For treatment of dengue hemorrhagic fever.
Advantages when compared to the existing technologies:
The pathogenesis of dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS), both serious complications of dengue virus (DV) infection, remains unclear. This is the first study that we identified the monoclonal autoantibody against dengue virus and identified the protein identity of the autoantigen.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
